The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
The Kallikrein-Kinin System: Current and Future Pharmacological Targets
Open accessAbstract
The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). This complex system includes the precursors of kinins known as kininogens and mainly tissue and plasma kallikreins. The pharmacologically active kinins, which are often considered as either proinflammatory or cardioprotective, are implicated in many physiological and pathological processes. The interest of the various components of this multi-protein system is explained in part by the multiplicity of its pharmacological activities, mediated not only by kinins and their receptors, but also by their precursors and their activators and the metallopeptidases and the antiproteases that limit their activities. The regulation of this system by serpins and the wide distribution of the different constituents add to the complexity of this system, as well as its multiple relationships with other important metabolic pathways such as the renin-angiotensin, coagulation, or complement pathways. The purpose of this review is to summarize the main properties of this kallikrein-kinin system and to address the multiple pharmacological interventions that modulate the functions of this system, restraining its proinflammatory effects or potentiating its cardiovascular properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During ACE inhibition, bradykinin is primarily inactivated by aminopeptidase P (APP).”
From Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema (2010) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
MEROPS: the peptidase database
Rawlings, N. D., & Barrett, A. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.325 · Cited by 2,284
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J., Arveiler, D., Luc, G., Bard, J., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,908
Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Research works printed but not linked: 5
- 1 Abelous J, Bardier E. Les substances hypotensives de l’urine humaine normale. CR Soc Biol. 1909;66:511-512. (in French)
- 209 Rosenkrans B, Russmann S, Reichen J, Brunner-Ferber F, Bork K, Knolle J. Clinical proof-of-concept fort he bradykinin B2 antagonist; icatibant in liver cirrhosis and hereditary angioedema. Peptide Receptors Montreal 2004 Symposium. Montreal, Canada, 2004.
- 222 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153. · DOI · Paper page
- 241 Dumoulin MJ, Lamontagne D, Burnett J, Heublein D, Yamaguchi N, Adam A. Respective role of endogenous kinins and natriuretic peptides in the cardioprotective effect of omapatrilat following total heart ischemia (abstract). Eur Heart J. 2001;22:50.
- 250 Duan Q, Nikpoor B, Molinaro G, Meijer I, Rochefort D, Saint-Onge J, et al. Variants in XPNPEP2 increase susceptibility to ACE-inhibitor associated adverse reactions. Am J Hum Genet. In press 2005.
Cited by
Sorted by citations
Acute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,064
A catalog of genetic loci associated with kidney function from analyses of a million individuals
Study, L. C., Wuttke, M., Program, V. A. M. V., Li, Y., Li, M., Sieber, K. B., Feitosa, M. F., Gorski, M., Tin, A., Wang, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0407-x · Cited by 842
Distribution of 15 Human Kallikreins in Tissues and Biological Fluids
Shaw, J. L. V., & Diamandis, E. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088104 · Cited by 390
Bernstein, K. E., Ong, F. S.-C., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., González-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 330
Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 299
Gender and the renin–angiotensin–aldosterone system
Komukai, K., Mochizuki, S., & Yoshimura, M. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00854.x · Cited by 295
Lawrence, M. G., Lai, J., & Clements, J. A. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0034 · Cited by 270
Unleashing the therapeutic potential of human kallikrein-related serine proteases
Prassas, I., Eissa, A., Poda, G. I., & Diamandis, E. P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4534 · Cited by 252
From snake venom toxins to therapeutics – Cardiovascular examples
Koh, C. Y., & Kini, R. M. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.03.017 · Cited by 239
Angiotensin-Converting Enzyme and Vascular Remodeling
Heeneman, S., Sluimer, J. C., & Daemen, M. J. A. P. (2007) · Circulation Research · doi:10.1161/circresaha.107.148338 · Cited by 224
Fungal Proteases and Their Pathophysiological Effects
Yike, I. (2011) · Mycopathologia · doi:10.1007/s11046-010-9386-2 · Cited by 223
Brown, N. J., Byiers, S., Carr, D., Maldonado, M., & Warner, B. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134197 · Cited by 223
Self-citationBradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors
Montana, V., & Sontheimer, H. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3825-10.2011 · Cited by 214
The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas
Petersen, O. H., Gerasimenko, J. V., Gerasimenko, O. V., Gryshchenko, O., & Peng, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00003.2021 · Cited by 182
New topics in bradykinin research
Maurer, M., Bader, M., Bas, M., Bossi, F., Cicardi, M., Cugno, M., Howarth, P., Kaplan, A., Kojda, G., Leeb‐Lundberg, F., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02686.x · Cited by 176
Medeiros, R., Passos, G. F., Vitor, C. E., Koepp, J., Mazzuco, T. L., Pianowski, L. F., Campos, M. M., & Calixto, J. B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707270 · Cited by 167
The Kallikrein‐Kinin System as a Regulator of Cardiovascular and Renal Function
Rhaleb, N., Yang, X., & Carretero, O. A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100053 · Cited by 166
Angiotensin-converting enzyme inhibitor-associated angioedema
Byrd, J. B., Adam, A., & Brown, N. J. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.08.001 · Cited by 160
Self-citationA comprehensive nomenclature for serine proteases with homology to tissue kallikreins
Lundwall, Å., Band, V., Blaber, M., Clements, J. A., Courty, Y., Diamandis, E. P., Fritz, H., Lilja, H. G., Malm, J., Maltais, L. J., et al. (2006) · Biological Chemistry · doi:10.1515/bc.2006.082 · Cited by 150
Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
Byrd, J. B., Touzin, K., Sile, S., Gainer, J. V., Yu, C., Nadeau, J., Adam, A., & Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.096552 · Cited by 147
Self-citationMode of action of cytokines on nociceptive neurons
Üçeyler, N., Schäfers, M., & Sommer, C. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1755-z · Cited by 139
Decrem, Y., Rath, G., Blasioli, V., Cauchie, P., Robert, S., Beaufays, J., Frère, J., Féron, O., Dogné, J., Dessy, C., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091007 · Cited by 136
The role of kinin receptors in cancer and therapeutic opportunities
da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.009 · Cited by 133
Zinc: An important cofactor in haemostasis and thrombosis
Vu, T. T. T., Fredenburgh, J. C., & Weitz, J. I. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0465 · Cited by 132
Chen, Z.-A., Wu, C. ‐., Wu, S., Huang, C.-Y., Mou, C., Wei, K., Yen, Y., Chien, I.-T., Runa, S., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08993 · Cited by 132
Fryer, R. M., Segreti, J., Banfor, P. N., Widomski, D. L., Backes, B. J., Lin, C. W., Ballaron, S. J., Cox, B. F., Trevillyan, J. M., Reinhart, G. A., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707641 · Cited by 130
The dual role of the contact system in bacterial infectious disease
Frick, I.-M., Björck, L., & Herwald, H. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0051 · Cited by 129
Heart failure and cognitive impairment: challenges and opportunities.
Heckman, G. A., Patterson, C. J., Demers, C., Onge, J. S., Turpie, I., & McKelvie, R. S. (2007) · PubMed · Cited by 131
Hoover, T. A., Lippmann, M. L., Grouzmann, E., Marceau, F., & Herscu, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03323.x · Cited by 127
Self-citationA hypothesized role for dysregulated bradykinin signaling in COVID‐19 respiratory complications
Roche, J. A., & Roche, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000967 · Cited by 127
Rosner, M. H., Portilla, D., & Okusa, M. D. (2008) · Journal of Intensive Care Medicine · doi:10.1177/0885066607309998 · Cited by 115
Silva, J., Monge‐Fuentes, V., Gomes, F. M. M., Lopes, K. S., dos Anjos, L. C., Campos, G. A. A., Arenas, C., Mayer, A. B., Gonçalves, J. C., Galante, P., et al. (2015) · Toxins · doi:10.3390/toxins7083179 · Cited by 114
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
Chao, J., Shen, B., Gao, L., Xia, C., Bledsoe, G., & Chao, L. (2010) · Biological Chemistry · doi:10.1515/bc.2010.042 · Cited by 113
Drouet, C., Désormeaux, A., Robillard, J., Ponard, D., Bouillet, L., Martin, L., Kanny, G., Moneret-Vautrin, D.-A., Bosson, J.-L., Quesada, J.-L., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.048 · Cited by 112
Self-citationBarros, C. C., Haro, A. S., Russo, F. J., Schadock, I., Almeida, S. S., Ribeiro, R. A., Vanzela, E. C., Lanzoni, V. P., Barros, F. C., Moraes, M. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040573 · Cited by 112
Massey, H. D., & McPherson, R. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00047-6 · Cited by 111
Angiotensin-converting Enzyme Inhibitor-induced Angioedema
Bezalel, S. R., Mahlab‐Guri, K., Asher, I., Werner, B., & Sthoeger, Z. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.011 · Cited by 110
Yi, J., Kim, C., & Gelfand, C. A. (2007) · Journal of Proteome Research · doi:10.1021/pr060550h · Cited by 110
Vasodilator factors in the systemic and local adaptations to pregnancy
Valdés, G., Kaufmann, P., Corthorn, J., Erices, R., Brosnihan, K. B., & Joyner, J. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-79 · Cited by 110
Kininogens: More than cysteine protease inhibitors and kinin precursors
Lalmanach, G., Naudin, C., Lecaille, F., & Fritz, H. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.011 · Cited by 109
Komatsu, N., Saijoh, K., Kuk, C., Shirasaki, F., Takehara, K., & Diamandis, E. P. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07743.x · Cited by 109
ACE inhibitor-mediated angioedema
Montinaro, V., & Cicardi, M. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106081 · Cited by 100
Wicik, Z., Eyileten, C., Jakubik, D., Simões, S. N., Martins, D., Pavão, R., Siller-Matula, J. M., & Postula, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113743 · Cited by 100
Campos, M. M., Leal, P. C., Yunes, R. A., & Calixto, J. Β. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.007 · Cited by 99
Sesquiterpenes from Essential Oils and Anti-Inflammatory Activity
Sá, R. D. C. D. S. E., Andrade, L. N., & de Sousa, D. P. (2015) · Natural Product Communications · doi:10.1177/1934578x1501001033 · Cited by 95
Ceconi, C., Francolini, G., Olivares, A., Comini, L., Bachetti, T., & Ferrari, R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.061 · Cited by 93
Woodard-Grice, A. V., Lucisano, A. C., Byrd, J. B., Stone, E. R., Simmons, W. H., & Brown, N. J. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833d3acb · Cited by 92
Self-citationAn Initial Characterization of the Serum Phosphoproteome
Zhou, W., Ross, M. M., Tessitore, A., Ornstein, D. K., VanMeter, A., Liotta, L. A., & Petricoin, E. F. (2009) · Journal of Proteome Research · doi:10.1021/pr900603n · Cited by 92
Cunha, T. M., Verri, W. A., Jr., Jr., Fukada, S. Y., Guerrero, A. T. G., Santodomingo-Garzón, T., Poole, S., Parada, C. A., Ferreira, S. H., & Cunha, F. Q. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.007 · Cited by 90
Kashuba, E., Bailey, J. R., Allsup, D. J., & Cawkwell, L. (2013) · Biomarkers · doi:10.3109/1354750x.2013.787544 · Cited by 88
Pain on injection with microemulsion propofol
Sim, J., Lee, S., Park, D., Jung, J., Ki, K., Lee, D., & Noh, G. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03358.x · Cited by 88
Dı́az-Araya, G., Vivar, R., Humeres, C. D., Boza, P., Bolívar, S., & Muñoz, C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.001 · Cited by 87
Kinin B1 receptors as a therapeutic target for inflammation
Qadri, F., & Bäder, M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1409724 · Cited by 82
Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells
Xu, J., Fang, J., Cheng, Z., Fan, L., Hu, W., Zhou, F., & Shen, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0833-0 · Cited by 80
Angiotensin-Converting Enzyme Inhibitors Induce Cough
Yılmaz, İ. (2018) · Turkish Thoracic Journal · doi:10.5152/turkthoracj.2018.18014 · Cited by 80
Bortone, F., Santos, H. A., Albertini, R., Pesquero, J. B., Costa, M. S., & Silva, J. A. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.09.004 · Cited by 78
Li, B., Suwan, J., Martin, J. G., Zhang, F., Zhang, Z., Hoppensteadt, D., Clark, M., Fareed, J., & Linhardt, R. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.012 · Cited by 78
Pathophysiology of Hereditary Angioedema
Caccia, S., Suffritti, C., & Cicardi, M. (2014) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2014.0425 · Cited by 77
Prediger, R. D., Medeiros, R., Pandolfo, P., Duarte, F. S., Passos, G. F., Pesquero, J. B., Campos, M. M., Calixto, J. Β., & Takahashi, R. N. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.009 · Cited by 77
Chao, J., Bledsoe, G., Yin, H. H., & Chao, L. (2006) · Biological Chemistry · doi:10.1515/bc.2006.085 · Cited by 77
Emami, N., & Diamandis, E. P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.09.003 · Cited by 76
Proteinases, Their Extracellular Targets, and Inflammatory Signaling
Ramachandran, R., Altier, C., Οικονομοπούλου, Κ., & Hollenberg, M. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010991 · Cited by 68
Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
Cruz, N. A. N., Stoll, D., Casarini, D. E., & Bertagnolli, M. (2021) · Clinical Science · doi:10.1042/cs20210284 · Cited by 67
Brechter, A. B., Persson, E., Lundgren, I., & Lerner, U. H. (2008) · Bone · doi:10.1016/j.bone.2008.02.003 · Cited by 67
Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
Defendi, F., Charignon, D., Ghannam, A., Baroso, R., Csopaki, F., Allegret-Cadet, M., Ponard, D., Favier, B., Cichon, S., Nicolie, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070140 · Cited by 67
Kinin receptors: Key regulators of autoimmunity
Dutra, R. C. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.12.011 · Cited by 66
Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it
Beltrami, L., Zingale, L. C., Carugo, S., & Cicardi, M. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.5.643 · Cited by 66
Foo, S., Cambou, M. C., Mok, T., Fajardo, V. M., Jung, K. L., Fuller, T. L., Chen, W., Kerin, T., Mei, J. Y., Bhattacharya, D., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100453 · Cited by 65
Leońska‐Duniec, A., Ahmetov, I. I., & Żmijewski, P. (2016) · Biology of Sport · doi:10.5604/20831862.1201052 · Cited by 62
Landmesser, U., & Drexler, H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220405.38622.23 · Cited by 62
Angioedema induced by angiotensin-converting enzyme inhibitors
Campo, P., Fernández, T. D., Cantó, G., & Mayorga, C. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328362b835 · Cited by 59
The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy
Gersh, F. L., O’Keefe, J. H., Lavie, C. J., & Henry, B. M. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.08.009 · Cited by 57
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril
Silva, P. S., Fontana, V., Luizon, M. R., Lacchini, R., silva, W. A., Biagi, C., & Tanus-Santos, J. E. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1326-2 · Cited by 56
“Nuts and Bolts” of Laboratory Evaluation of Angioedema
Farkas, H., Veszeli, N., Kajdácsi, E., Cervenak, L., & Varga, L. Á. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8539-6 · Cited by 56
Nagai, N., Oike, Y., Izumi‐Nagai, K., Koto, T., Satofuka, S., Shinoda, H., Noda, K., Ozawa, Y., Inoue, M., Tsubota, K., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1296 · Cited by 55
Hillmeister, P., & Persson, P. B. (2012) · Acta Physiologica · doi:10.1111/apha.12007 · Cited by 54
Seliga, A., Lee, M. H., Fernandes, N. C., Zuluaga‐Ramirez, V., Didukh, M., Persidsky, Y., Potula, R., Gallucci, S., & Sriram, U. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00156 · Cited by 54
Review: The angiogenic and vasodilatory utero-placental network
Valdés, G., & Corthorn, J. (2011) · Placenta · doi:10.1016/j.placenta.2011.01.008 · Cited by 54
Computational Intelligence for Medical Imaging Simulations
Chang, V. I. C. (2017) · Journal of Medical Systems · doi:10.1007/s10916-017-0861-x · Cited by 52
Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK
Mount, P. F., Lane, N., Venkatesan, S., Steinberg, G. R., Fraser, S. A., Kemp, B. E., & Power, D. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.003 · Cited by 52
Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells
Wang, G., Ye, Y., Zhang, X., & Song, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3366 · Cited by 51
Targeting TRPV1 as an Alternative Approach to Narcotic Analgesics to Treat Chronic Pain Conditions
Premkumar, L. S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9196-y · Cited by 51
Diabetic Peripheral Neuropathy: Role of Reactive Oxygen and Nitrogen Species
Premkumar, L. S., & Pabbidi, R. M. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9609-5 · Cited by 51
Zhang, Y., Cardell, L., Edvinsson, L. I., & Xu, C. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.004 · Cited by 50
Current Concepts of Neurohormonal Activation in Heart Failure
Lee, C. S., & Tkacs, N. C. (2008) · AACN Advanced Critical Care · doi:10.1097/01.aacn.0000340718.93742.c4 · Cited by 50
Targeting the ‘Janus face' of the B2-bradykinin receptor
Blaes, N., & Girolami, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827664 · Cited by 49
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
Diksin, M., Smith, S. J., & Rahman, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112342 · Cited by 49
Kaufman, G., Zaouter, C., Valteau, B., Sirois, P., & Moldovan, F. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3338 · Cited by 49
Wen, H., Chuu, C., Chen, C., Shiah, S., Kung, H.-J., King, K., Su, L.-C., Chang, S.-C., & Chang, C.-H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125518 · Cited by 48
Bradykinin Metabolism and Drug-Induced Angioedema
Smolińska, S., Antolín‐Amérigo, D., & Popescu, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411649 · Cited by 47
Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
Asraf, K., Torika, N., Apte, R. N., & Fleisher‐Berkovich, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00116 · Cited by 49
Fukuda, K., Hirooka, K., Mizote, M., Nakamura, T., Itano, T., & Shiraga, F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4107 · Cited by 46
Conceição, K., Konno, K., Melo, R. L. D., Antoniazzi, M. M., Jared, C., Sciani, J. M., Conceição, I. M., Prezoto, B. C., de Camargo, A. C. M., & Pimenta, D. C. (2006) · Peptides · doi:10.1016/j.peptides.2006.10.002 · Cited by 46
Evaluation and management of angioedema of the head and neck
Baş, M., Hoffmann, T. K., & Kojda, G. (2006) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/01.moo.0000193202.85837.7d · Cited by 45
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
Charignon, D., Späth, P., Martin, L., & Drouet, C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.723692 · Cited by 44
Zhang, Q., Ding, H., Yan, J., Wang, W., Ma, A., Zhu, Z., Cianflone, K., Hu, F. B., Hui, R., & Wang, D. W. (2011) · Annals of Neurology · doi:10.1002/ana.22404 · Cited by 44
Current pharmacotherapy of bradykinin-mediated angioedema
Farkas, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.778826 · Cited by 44
Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
Naaldijk, Y., Bittencourt, M. C., Sack, U., & Ulrich, H. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0257 · Cited by 44
SHINBARA, H., Okubo, M., Sumiya, E., FUKUDA, F., Yano, T., & KITADE, T. (2008) · Acupuncture in Medicine · doi:10.1136/aim.26.3.149 · Cited by 43
Busse, P. J., & Kaplan, A. P. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.11.011 · Cited by 43
Metadata
- Authors
- Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A.
- Affiliations
- Université de Montréal (CA)
- University of Liège (BE)
- Vanderbilt University (US)
- Centre hospitalier universitaire de Québec (CA)
- Venue
- Journal of Pharmacological Sciences
- Publisher
- Japanese Pharmacological Society
- Published
- 2005
- Volume
- 99
- Issue
- 1
- Pages
- 6-38
- ISSN
- 1347-8613 (ISSN-L)
- 1347-8648
- OpenAlex
- W1967632907
- Semantic Scholar
- 11ef9af17a7b09227baf4d743022d17406b6c59a
- Cited by
- 457
- References
- 324
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 19 · 2023: 14 · 2022: 7 · 2021: 20 · 2020: 24 · 2019: 9 · 2018: 20 · 2017: 13 · 2016: 29 · 2015: 23 · 2014: 24 · 2013: 37 · 2012: 33
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079184)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- kallikrein-kinin system, bradykinin, kininogen, tissue kallikrein, plasma kallikrein, kinin receptors, metalloproteinases, antiproteases, serpins, pro-inflammatory effects, cardioprotection, renin-angiotensin system, coagulation, complement system, therapeutic target
- MeSH terms
- Angioedema, Angiotensin-Converting Enzyme Inhibitors, Animals, Bradykinin, Cardiovascular Diseases, Complement C1 Inactivator Proteins, Humans, Inflammation, Kallikreins, Aprotinin, Kidney Diseases, Peptidyl-Dipeptidase A, Kinins, Polymorphism, Genetic, Pyridines, Thiazepines, Neprilysin, Serpins, Randomized Controlled Trials as Topic, Kallikrein-Kinin System, Receptor, Bradykinin B2, Receptor, Bradykinin B1, Complement C1 Inhibitor Protein, Bradykinin B2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review